Published in
Wiley, Hepatology Research, 3(50), p. 382-395, 2019
DOI: 10.1111/hepr.13460
Links
Tools
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study
Journal article published in 2019 by
Takeshi Hatanaka 
,
Satoru Kakizaki ,
Tamon Nagashima,
Masashi Namikawa,
Hiroki Tojima ,
Yasushi Shimada,
Daichi Takizawa,
Atsushi Naganuma ,
Hirotaka Arai ,
Ken Sato ,
Norifumi Harimoto,
Ken Shirabe,
Toshio Uraoka
,
Satoru Kakizaki ,
Tamon Nagashima,
Masashi Namikawa,
Hiroki Tojima ,
Yasushi Shimada,
Daichi Takizawa,
Atsushi Naganuma ,
Hirotaka Arai ,
Ken Sato ,
Norifumi Harimoto,
Ken Shirabe,
Toshio Uraoka
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 